132.65
前日終値:
$136.36
開ける:
$136.36
24時間の取引高:
1.56M
Relative Volume:
1.10
時価総額:
$19.45B
収益:
$9.61B
当期純損益:
$1.53B
株価収益率:
12.68
EPS:
10.46
ネットキャッシュフロー:
$1.85B
1週間 パフォーマンス:
-4.65%
1か月 パフォーマンス:
+2.61%
6か月 パフォーマンス:
-5.17%
1年 パフォーマンス:
-35.04%
Biogen Inc Stock (BIIB) Company Profile
BIIB を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BIIB
Biogen Inc
|
132.65 | 19.99B | 9.61B | 1.53B | 1.85B | 10.46 |
![]()
LLY
Lilly Eli Co
|
731.96 | 658.15B | 53.26B | 13.80B | -50.20M | 15.30 |
![]()
JNJ
Johnson Johnson
|
175.45 | 425.77B | 90.62B | 22.66B | 18.18B | 9.35 |
![]()
ABBV
Abbvie Inc
|
207.92 | 367.55B | 58.33B | 3.73B | 18.24B | 2.10 |
![]()
NVS
Novartis Ag Adr
|
126.47 | 245.64B | 53.40B | 13.68B | 16.89B | 6.9231 |
![]()
MRK
Merck Co Inc
|
83.21 | 209.99B | 63.43B | 16.42B | 14.72B | 6.49 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-07-21 | 再開されました | Truist | Hold |
2025-04-28 | ダウングレード | HSBC Securities | Buy → Hold |
2025-04-04 | ダウングレード | Argus | Buy → Hold |
2025-02-11 | 開始されました | Bernstein | Mkt Perform |
2025-01-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
2024-12-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2024-12-16 | ダウングレード | Stifel | Buy → Hold |
2024-12-10 | 再開されました | BofA Securities | Neutral |
2024-12-09 | ダウングレード | Jefferies | Buy → Hold |
2024-11-18 | ダウングレード | Needham | Buy → Hold |
2024-11-15 | 開始されました | Wolfe Research | Peer Perform |
2024-11-14 | 開始されました | Citigroup | Neutral |
2024-10-31 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2024-10-10 | 再開されました | Raymond James | Mkt Perform |
2024-02-14 | 繰り返されました | Needham | Buy |
2024-02-14 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2024-01-24 | ダウングレード | UBS | Buy → Neutral |
2023-12-20 | 再開されました | Cantor Fitzgerald | Overweight |
2023-12-07 | アップグレード | Raymond James | Mkt Perform → Outperform |
2023-09-06 | 開始されました | HSBC Securities | Buy |
2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
2023-07-24 | 繰り返されました | UBS | Buy |
2023-05-01 | アップグレード | Guggenheim | Neutral → Buy |
2023-04-17 | アップグレード | Piper Sandler | Neutral → Overweight |
2022-10-26 | アップグレード | Goldman | Neutral → Buy |
2022-10-13 | アップグレード | Stifel | Hold → Buy |
2022-10-07 | アップグレード | Argus | Hold → Buy |
2022-09-28 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2022-09-28 | アップグレード | Mizuho | Neutral → Buy |
2022-09-28 | アップグレード | Robert W. Baird | Neutral → Outperform |
2022-04-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2022-03-08 | ダウングレード | Stifel | Buy → Hold |
2022-03-03 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2022-02-04 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2022-02-04 | 繰り返されました | Barclays | Equal Weight |
2022-02-04 | 繰り返されました | BofA Securities | Neutral |
2022-02-04 | 繰り返されました | Cowen | Outperform |
2022-02-04 | 繰り返されました | Morgan Stanley | Overweight |
2022-02-04 | 繰り返されました | Needham | Buy |
2022-02-04 | 繰り返されました | Oppenheimer | Outperform |
2022-02-04 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2022-02-04 | 繰り返されました | Robert W. Baird | Neutral |
2022-02-04 | 繰り返されました | Wedbush | Neutral |
2022-02-04 | 繰り返されました | Wells Fargo | Equal Weight |
2022-02-04 | 繰り返されました | Wolfe Research | Peer Perform |
2022-01-13 | ダウングレード | Guggenheim | Buy → Neutral |
2022-01-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
2021-12-10 | 再開されました | Raymond James | Mkt Perform |
2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
2021-12-06 | 開始されました | Goldman | Neutral |
2021-11-19 | 開始されました | BMO Capital Markets | Outperform |
2021-09-23 | 開始されました | Needham | Buy |
2021-06-18 | アップグレード | Piper Sandler | Neutral → Overweight |
2021-06-14 | 繰り返されました | Truist | Buy |
2021-06-11 | アップグレード | Bernstein | Mkt Perform → Outperform |
2021-06-10 | アップグレード | UBS | Neutral → Buy |
2021-06-08 | アップグレード | Atlantic Equities | Underweight → Neutral |
2021-06-08 | 繰り返されました | Barclays | Equal Weight |
2021-06-08 | アップグレード | Citigroup | Sell → Neutral |
2021-06-08 | 繰り返されました | H.C. Wainwright | Buy |
2021-06-08 | 繰り返されました | Jefferies | Buy |
2021-06-08 | 繰り返されました | Morgan Stanley | Overweight |
2021-06-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2021-06-08 | アップグレード | Robert W. Baird | Underperform → Neutral |
2021-06-08 | 繰り返されました | Stifel | Buy |
2021-06-08 | アップグレード | William Blair | Mkt Perform → Outperform |
2021-06-07 | アップグレード | BofA Securities | Underperform → Neutral |
2021-06-07 | アップグレード | Cowen | Market Perform → Outperform |
2021-06-07 | アップグレード | Raymond James | Underperform → Mkt Perform |
2021-02-05 | ダウングレード | DZ Bank | Buy → Hold |
2021-01-29 | アップグレード | Stifel | Hold → Buy |
2020-11-10 | アップグレード | DZ Bank | Hold → Buy |
2020-11-09 | ダウングレード | Atlantic Equities | Neutral → Underweight |
2020-11-09 | ダウングレード | BofA Securities | Neutral → Underperform |
2020-11-09 | ダウングレード | Cowen | Outperform → Market Perform |
2020-11-09 | 繰り返されました | H.C. Wainwright | Buy |
2020-11-04 | アップグレード | BofA Securities | Underperform → Neutral |
2020-11-04 | アップグレード | Jefferies | Hold → Buy |
2020-11-04 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2020-10-28 | 開始されました | UBS | Neutral |
2020-07-27 | アップグレード | Morgan Stanley | Underweight → Overweight |
2020-06-22 | ダウングレード | Barclays | Overweight → Equal Weight |
2020-06-22 | 繰り返されました | RBC Capital Mkts | Sector Perform |
2020-06-09 | ダウングレード | Bernstein | Outperform → Mkt Perform |
2020-04-23 | ダウングレード | Citigroup | Neutral → Sell |
2020-04-23 | ダウングレード | Raymond James | Mkt Perform → Underperform |
2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
2020-02-27 | 開始されました | Barclays | Overweight |
2020-01-27 | アップグレード | Canaccord Genuity | Hold → Buy |
2019-12-13 | アップグレード | Credit Suisse | Underperform → Neutral |
2019-12-02 | ダウングレード | Robert W. Baird | Neutral → Underperform |
すべてを表示
Biogen Inc (BIIB) 最新ニュース
What does recent volatility data suggest for Biogen Inc.Options Play & Long-Term Capital Growth Ideas - Newser
Price T Rowe Associates Inc. MD Sells 782,524 Shares of Biogen Inc. $BIIB - MarketBeat
Visualizing Biogen Inc. stock with heatmapsJuly 2025 Movers & Reliable Volume Spike Alerts - Newser
HighTower Advisors LLC Has $1.60 Million Stock Position in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. $BIIB Shares Purchased by Korea Investment CORP - MarketBeat
US FDA’s ARIA Analysis Adds Earlier Scan To Biogen/Eisai Leqembi Label - insights.citeline.com
Is Biogen Inc. stock ready for a breakoutRecession Risk & Technical Pattern Recognition Alerts - Newser
Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA recommends more monitoring of Alzheimer's patients on Eisai-Biogen's drug Leqembi - Reuters
FDA recommends more monitoring of Alzheimer's patients on Biogen's drug Leqembi - Reuters
Regulatory Vigilance and the Future of Biogen’s Leqembi: Balancing Innovation with Risk in Alzheimer’s Drug Development - AInvest
Will a bounce in Biogen Inc. offer an exit2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
Evaluating Biogen Inc. with trendline analysisTrade Risk Summary & Expert Curated Trade Setup Alerts - Newser
Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study - Benzinga
Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight - GlobeNewswire Inc.
Stock Analysis | Biogen OutlookNavigating Bearish Signals Amid Mixed Analyst Sentiment - AInvest
Biogen Inc. stock chart pattern explainedJuly 2025 Recap & Fast Entry Momentum Alerts - Newser
Custom watchlist performance reports with Biogen Inc.Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - Newser
Biogen Inc. $BIIB Shares Purchased by FORA Capital LLC - MarketBeat
Altrinsic Global Advisors LLC Reduces Stake in Biogen Inc. $BIIB - MarketBeat
Causeway Capital Management LLC Raises Stock Position in Biogen Inc. $BIIB - MarketBeat
Synovus Financial Corp Grows Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Campbell & CO Investment Adviser LLC Reduces Stock Position in Biogen Inc. $BIIB - MarketBeat
APG Asset Management N.V. Sells 9,014 Shares of Biogen Inc. $BIIB - MarketBeat
Will Biogen Inc. stock go up soon2025 Market Overview & Fast Moving Market Watchlists - Newser
Developing predictive dashboards with Biogen Inc. data2025 Top Decliners & Low Risk Growth Stock Ideas - Newser
Can volume confirm reversal in Biogen Inc.July 2025 Earnings & Consistent Growth Equity Picks - Newser
Biogen Inc. stock daily chart insights2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - Newser
Biogen’s Zurzuvae and the Expanding Postnatal Depression Treatment Market: A Catalyst for Long-Term Growth in Maternal Mental Health - AInvest
Biogen Inc. $BIIB Shares Sold by Northern Trust Corp - MarketBeat
Level Four Advisory Services LLC Buys 8,685 Shares of Biogen Inc. $BIIB - MarketBeat
Multi factor analysis applied to Biogen Inc.2025 Top Gainers & Verified Entry Point Signals - Newser
Dimensional Fund Advisors LP Reduces Holdings in Biogen Inc. $BIIB - MarketBeat
Quantbot Technologies LP Grows Position in Biogen Inc. $BIIB - MarketBeat
UK Regulator Approves Biogen’s Drug For Treating Postnatal Depression - MSN
Biogen Dips 0.26% as $0.19B Volume Ranks 491st in Market Activity Amid Global Smart Shelves Market Surge - AInvest
Can trapped investors hope for a rebound in Biogen Inc.Earnings Miss & Real-Time Volume Analysis Alerts - Newser
Biogen wins approval of postpartum depression drug Zurzuvae in UK - Seeking Alpha
Analyzing drawdowns of Biogen Inc. with statistical toolsEarnings Overview Summary & Weekly Sector Rotation Insights - Newser
Biogen Partnership and Zorevunersen Data Could Be a Game Changer for Stoke Therapeutics (STOK) - simplywall.st
Biogen Inc (BIIB) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):